Pharmacokinetic Study of Testosterone Enanthate

Completed · Phase 1/Phase 2

Conditions studied: Hypogonadism

In brief

Relative Bioavailability and Safety comparison of 3 formulations of Testosterone Enanthate.

Key facts

Study ID

NCT01887418

Run by

Antares Pharma Inc.

People needed

39

Starts

2013-09-01

Expected to finish

2014-01-01

Last updated by the study team

2018-01-11

Who can join

Age: 18 and older, up to 75. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Adult males aged 18 to 75 with a documented diagnosis of hypogonadism

You may not qualify if…

• Normal testosterone levels
• Subjects with any clinically significant medical condition which, in the opinion of the Investigator, would make the subject an unsuitable candidate for enrollment in the study

Where it is running

• Mens Health Boston — Brookline, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.